Altium Capital

Altium Capital is a New York-based healthcare-focused investment firm that provides growth capital to private and public companies developing technologies for human health. The firm is relevant for later-stage venture and growth opportunities in biotechnology, HealthTech, life sciences, therapeutics, pharmaceuticals, medical devices, oncology, and healthcare analytics across the United States. Its portfolio includes companies such as Hyperfine, Immunovant, Cerevel Therapeutics, and Yumanity Therapeutics.